Global Parenteral Nutrition Market

Parenteral Nutrition Market Size, Share, Growth Analysis, By Consumer(Children and Newborns, and Adults), By End user(Clinics, Hospitals) - Industry Forecast 2024-2031


Report ID: SQMIG35C2022 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 62 | Figures: 75

Parenteral Nutrition Market Regional Insights

The dominance of North America can be attributed to several factors, including the presence of well-established healthcare infrastructure, advanced medical technologies, and high healthcare expenditure. Additionally, the region has a high prevalence of chronic diseases, an aging population, and a strong focus on research and development activities, which contribute to the demand for parenteral nutrition therapies. Moreover, the presence of major pharmaceutical and healthcare companies in North America further strengthens its dominant position in the market.

The fastest-growing region in the parenteral nutrition market is expected to be Asia Pacific. The Asia Pacific region has witnessed significant growth in recent years due to various factors. The increasing prevalence of chronic diseases, rapid urbanization, and improving healthcare infrastructure in countries like China and India are driving the demand for parenteral nutrition therapies. Additionally, the rising disposable income and expanding middle-class population in the region have led to increased healthcare spending and accessibility to advanced medical treatments. Furthermore, the focus on improving healthcare facilities, the adoption of innovative technologies, and the growing awareness about nutrition and wellness are fueling the market growth in the Asia Pacific region.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Parenteral Nutrition Market size was valued at USD 6.33 Billion in 2021 and is poised to grow from USD 6.71 Billion in 2022 to USD 10.7 Billion by 2030, at a CAGR of 6.0% during the forecast period (2023-2030).

The parenteral nutrition market is highly competitive and characterized by the presence of several key players striving to capture a significant share of the market. These companies are continuously engaged in research and development activities to introduce innovative products and gain a competitive edge. The competitive landscape is shaped by factors such as product offerings, technological advancements, pricing strategies, distribution networks, and partnerships. Market players in the parenteral nutrition industry focus on expanding their product portfolios by introducing new formulations and customized solutions to cater to specific patient needs. 'Fresenius Kabi (Germany)', 'B. Braun Melsungen AG (Germany)', 'Baxter International Inc. (US)', 'Grifols SA (Spain)', 'Otsuka Pharmaceutical Co., Ltd. (Japan)', 'Pfizer Inc. (US)', 'Aculife Healthcare Pvt. Ltd. (India)', 'Vifor Pharma (Switzerland)', 'Sichuan Kelun Pharmaceutical Co., Ltd. (China)', 'ALLERGAN (Ireland)', 'Claris Lifesciences Limited (India)', 'Actavis plc (Ireland)', 'ABBOTT (US)', 'AstraZeneca (UK)', 'Medtronic (Ireland)', 'Beximco Pharmaceuticals Ltd. (Bangladesh)', 'Sichuan Luye Pharmaceutical Co., Ltd. (China)', 'ICU Medical, Inc. (US)', 'JW Pharmaceutical Corporation (South Korea)', 'Hospira, Inc. (US)'

The development of innovative formulations, improved nutrient combinations, and advanced delivery systems has enhanced the safety and efficacy of parenteral nutrition therapy. These advancements have made parenteral nutrition administration more convenient for healthcare providers and more tolerable for patients.

Integration of Digital Health Technologies: Digital health technologies, such as mobile applications, connected devices, and telehealth solutions, are being integrated into parenteral nutrition therapy. These technologies enable remote monitoring, real-time data collection, and improved communication between patients, caregivers, and healthcare providers, leading to better patient management and enhanced treatment outcomes.

The dominance of North America can be attributed to several factors, including the presence of well-established healthcare infrastructure, advanced medical technologies, and high healthcare expenditure. Additionally, the region has a high prevalence of chronic diseases, an aging population, and a strong focus on research and development activities, which contribute to the demand for parenteral nutrition therapies. Moreover, the presence of major pharmaceutical and healthcare companies in North America further strengthens its dominant position in the market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Parenteral Nutrition Market

Product ID: SQMIG35C2022

$5,300
BUY NOW GET FREE SAMPLE